Psoriatic Arthritis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Sun Pharma, Bristol-Myers Squibb, Nimbus Therapeutic, UCB Biopharma, Pfizer, ACELYRIN Inc.

DelveInsight's "Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Psoriatic Arthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Psoriatic Arthritis Market Forecast
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Psoriatic Arthritis Market Report:
• The Psoriatic Arthritis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• As many as 2.4 million Americans, or 30% of those with psoriasis, go on to develop psoriatic arthritis (PsA), which can strike at any age, according to the National Psoriatic Foundation
• Grellmann et al. [2020] conducted a retrospective analysis of German healthcare insurance data and discovered that PsA prevalence rates were 0.3% in 2016
• The National Institute for Health and Clinical Excellence (NICE) estimates that 0.1% to 0.3% of the population in the UK suffers with psoriatic arthritis.
• Key Psoriatic Arthritis Companies: Sun Pharma, Bristol-Myers Squibb, Nimbus Therapeutic, UCB Biopharma, Pfizer, ACELYRIN Inc., MoonLake Immunotherapeutics AG, Aclaris Therapeutics, Inc., Ventyx Biosciences, Inc, Novartis, UCB Biopharma SRL, Suzhou Suncadia Biopharma, Amgen, Pfizer, Bio-Thera Solutions, Takeda, and others
• Key Psoriatic Arthritis Therapies: Ilumya, Deucravacitinib, NDI-034858, Bimekizumab, Brepocitinib, Izokibep, Sonelokimab, ATI-450, VTX958, AIN457 (secukinumab), Bimekizumab, SHR-1314 injection, Apremilast, Tofacitinib, BAT2506, NDI-034858, and others
• The Psoriatic Arthritis epidemiology based on gender analyzed that there is no gender based difference but prevalence of severe cases is the highest followed by moderate and mild
• The Psoriatic Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Psoriatic Arthritis pipeline products will significantly revolutionize the Psoriatic Arthritis market dynamics.

Psoriatic Arthritis Overview
Psoriatic arthritis (PsA) is a diverse type of chronic inflammatory rheumatic illness that causes joint erosion, bone growth, stiffness, pain, and swelling. Clinical signs differ widely from patient to patient. It can manifest as a polyarticular illness affecting five or more joints, frequently with an asymmetric distribution comparable to that of rheumatoid arthritis, or as oligoarticular joint involvement that is typically asymmetric.

Get a Free sample for the Psoriatic Arthritis Market Report
https://www.delveinsight.com/report-store/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriatic Arthritis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Psoriatic Arthritis Epidemiology Segmentation:
The Psoriatic Arthritis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Psoriatic Arthritis
• Prevalent Cases of Psoriatic Arthritis by severity
• Gender-specific Prevalence of Psoriatic Arthritis
• Diagnosed Cases of Episodic and Chronic Psoriatic Arthritis

Download the report to understand which factors are driving Psoriatic Arthritis epidemiology trends @ Psoriatic Arthritis Epidemiology Forecast
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriatic Arthritis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Psoriatic Arthritis market or expected to get launched during the study period. The analysis covers Psoriatic Arthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Psoriatic Arthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Psoriatic Arthritis Therapies and Key Companies
• Ilumya: Sun Pharma
• Deucravacitinib: Bristol-Myers Squibb
• NDI-034858: Nimbus Therapeutic
• Bimekizumab: UCB Biopharma
• Brepocitinib: Pfizer
• Izokibep: ACELYRIN Inc.
• Sonelokimab: MoonLake Immunotherapeutics AG
• ATI-450: Aclaris Therapeutics, Inc.
• VTX958: Ventyx Biosciences, Inc
• AIN457 (secukinumab): Novartis
• Bimekizumab: UCB Biopharma SRL
• SHR-1314 injection: Suzhou Suncadia Biopharma
• Apremilast: Amgen
• Tofacitinib: Pfizer
• BAT2506: Bio-Thera Solutions
• NDI-034858: Takeda

Discover more about therapies set to grab major Psoriatic Arthritis market share @ Psoriatic Arthritis Treatment Market
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriatic Arthritis Market Strengths
• Widespread prevalence of the disease.
• The robust clinical pipeline containing emerging drugs with novel RoA and MoA holds promising future therapies.

Psoriatic Arthritis Market Opportunities
• Challenges in diagnoses
• Development of novel therapies
• Limitations in gene therapy
• Poor disease understanding
• Clinical biomarkers

Scope of the Psoriatic Arthritis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Psoriatic Arthritis Companies: Sun Pharma, Bristol-Myers Squibb, Nimbus Therapeutic, UCB Biopharma, Pfizer, ACELYRIN Inc., MoonLake Immunotherapeutics AG, Aclaris Therapeutics, Inc., Ventyx Biosciences, Inc, Novartis, UCB Biopharma SRL, Suzhou Suncadia Biopharma, Amgen, Pfizer, Bio-Thera Solutions, Takeda, and others
• Key Psoriatic Arthritis Therapies: Ilumya, Deucravacitinib, NDI-034858, Bimekizumab, Brepocitinib, Izokibep, Sonelokimab, ATI-450, VTX958, AIN457 (secukinumab), Bimekizumab, SHR-1314 injection, Apremilast, Tofacitinib, BAT2506, NDI-034858, and others
• Psoriatic Arthritis Therapeutic Assessment: Psoriatic Arthritis current marketed and Psoriatic Arthritis emerging therapies
• Psoriatic Arthritis Market Dynamics: Psoriatic Arthritis market drivers and Psoriatic Arthritis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Psoriatic Arthritis Unmet Needs, KOL's views, Analyst's views, Psoriatic Arthritis Market Access and Reimbursement

To know more about Psoriatic Arthritis companies working in the treatment market, visit @ Psoriatic Arthritis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Psoriatic Arthritis Market Report Introduction
2. Executive Summary for Psoriatic Arthritis
3. SWOT analysis of Psoriatic Arthritis
4. Psoriatic Arthritis Patient Share (%) Overview at a Glance
5. Psoriatic Arthritis Market Overview at a Glance
6. Psoriatic Arthritis Disease Background and Overview
7. Psoriatic Arthritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Psoriatic Arthritis
9. Psoriatic Arthritis Current Treatment and Medical Practices
10. Psoriatic Arthritis Unmet Needs
11. Psoriatic Arthritis Emerging Therapies
12. Psoriatic Arthritis Market Outlook
13. Country-Wise Psoriatic Arthritis Market Analysis (2019-2032)
14. Psoriatic Arthritis Market Access and Reimbursement of Therapies
15. Psoriatic Arthritis Market Drivers
16. Psoriatic Arthritis Market Barriers
17. Psoriatic Arthritis Appendix
18. Psoriatic Arthritis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Psoriatic Arthritis Pipeline https://www.delveinsight.com/report-store/psoriatic-arthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Psoriatic Arthritis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Psoriatic Arthritis market. A detailed picture of the Psoriatic Arthritis pipeline landscape is provided, which includes the disease overview and Psoriatic Arthritis treatment guidelines.
Psoriatic Arthritis Epidemiology https://www.delveinsight.com/report-store/psoriatic-arthritis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Psoriatic Arthritis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Psoriatic Arthritis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight

Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.